Current Psychopharmacology
Title:Editorial: Glutamatergic Mechanisms in Depression: Focus on D-cycloserine
Volume: 6
Author(s): Andrea R. Durrant and Uriel Heresco-Levy
Affiliation:
Export Options
About this article
Cite this article as:
Durrant R. Andrea and Heresco-Levy Uriel , Editorial: Glutamatergic Mechanisms in Depression: Focus on D-cycloserine, Current Psychopharmacology 2017; 6 (2) . https://dx.doi.org/10.2174/221155600602180102105314
DOI https://dx.doi.org/10.2174/221155600602180102105314 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Graphical Abstracts
Letters in Organic Chemistry Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Do Pharmacological Approaches that Prevent Opioid Tolerance Target Different Elements in the Same Regulatory Machinery?
Current Drug Abuse Reviews Discovery of a Small Molecule Inhibitor of the Interaction Between HIV-1 Proteins and Cellular Cofactors: A Novel Candidate Anti-HIV-1 Drug
Current Chemical Biology Evidence Based Psychosocial Practices and Recovery from Schizophrenia
Current Psychiatry Reviews Structure-Activity Relationship and Efficacy of Pyridinium Oximes in the Treatment of Poisoning with Organophosphorus Compounds: A Review of Recent Data
Current Topics in Medicinal Chemistry Pathology of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Commentary (Brilliant Blue G: What a Little More Colour Can Be)
CNS & Neurological Disorders - Drug Targets Identification of Electrophysiological Changes in Alzheimer's Disease: A Microarray Based Transcriptomics and Molecular Pathway Analysis Study
CNS & Neurological Disorders - Drug Targets Detoxification Depot for β -Amyloid Peptides
Current Alzheimer Research The Evolving Therapy of Rheumatic Diseases, The Future is Now
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Migration and Function of Th17 Cells
Inflammation & Allergy - Drug Targets (Discontinued) Interferon-γ-Induced Conversion of Tryptophan: Immunologic and Neuropsychiatric Aspects
Current Medicinal Chemistry 5HT1F- and 5HT7-Receptor Agonists for the Treatment of Migraines
CNS & Neurological Disorders - Drug Targets Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders
Current Vascular Pharmacology Herbal and Holistic Solutions for Neurodegenerative and Depressive Disorders: Leads from Ayurveda
Current Pharmaceutical Design Metabolic Fate of Endocannabinoids
Current Neuropharmacology Interactions of Sex Steroids with Mechanisms of Inflammation
Current Drug Targets - Inflammation & Allergy The Involvement of Post-Translational Modifications in Alzheimer's Disease
Current Alzheimer Research Efficacy of Montelukast as Added Therapy in Patients with Chronic Idiopathic Urticaria
Inflammation & Allergy - Drug Targets (Discontinued)